Skip to main content
. Author manuscript; available in PMC: 2011 Jan 12.
Published in final edited form as: Curr Alzheimer Res. 2010 Nov 1;7(7):642–651. doi: 10.2174/156720510793499075

Table 4.

Examples of Pre-Phase III CT Checklist Items

Issue Resulting Error Risk Assessment Acceptable Outcome?
Is Accuracy evidenced for outcome
measure(s)?
Yes or No?
Inaccuracy of endpoint measures
resulting in high variance.
What is the chance that inaccuracy
will undermine the validity of the
study data set?
P = 0….
Is this an acceptable risk?
Yes or No?
Is Dosing optimized?
Yes or No?
Lack of efficacy if doses are too low
or toxicity if too high.
What is the chance that dosing is not
optimized for the drug and its efficacy
can not be tested?
P = 0….
Is this an acceptable risk?
Yes or No?
Will sites comply with protocol
conditions?
Yes or No?
Enrollment of inappropriate patients
not fitting protocol criteria.
What is the chance that sites will not
comply with protocol conditions?
p = 0….
Is this an acceptable risk?
Yes or No?
Will investigators comply with
prior agreed analysis of primary
and secondary endpoints?
Yes or No?
Possible introduction of bias with
modifications of protocol after study
initiated.
What is the chance that the protocol
changes will bias the study analyses
or interpretations?
P = 0….
Is this an acceptable risk?
Yes or No?